
Combination pod-intravaginal ring delivers antiretroviral agents for HIV prophylaxis: pharmacokinetic evaluation in an ovine model
April 2016
Click for full info +Combination pod-intravaginal ring delivers antiretroviral agents for HIV prophylaxis: pharmacokinetic evaluation in an ovine model
![]() | 11 April 2016 |
In this Journal Article:
Health Risk(s):HIV
Product Type(s):ARVs IVR (Intravaginal Rings)
Topic(s):Product Development
Full Info:
Resource Type:
Citation:
Moss, J.A., Butkyavichene, I., Churchman, S.A., Gunawardana, M., Fanter, R., Miller, C.S., …& Baum, M.M. (2016, April 11). Antimicrobial Agents and Chemotherapy, 60(5).
Authors:
Moss, J.A., Butkyavichene, I., Churchman, S.A., Gunawardana, M., Fanter, R., Miller, C.S., …& Baum, M.M.
Health Risks(s):
- HIV
Product type(s):
- AVRs
- IVR
Topic(s):
- Development
URL of resource:
http://aac.asm.org/content/early/2016/04/05/AAC.00391-16.abstract